As the vanguard of CRISPR-based gene editing, CD Biosynsis' platform is dedicated to driving innovation, accelerating scientific discovery, and empowering industries to shape a genetically enhanced future.
CRISPR-based gene editing stands as a revolutionary technique in synthetic biology. It involves utilizing the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system, along with the Cas9 protein, to accurately target and modify specific DNA sequences within a genome. This molecular tool has transformed the landscape of genetic engineering, allowing scientists to achieve unprecedented levels of precision in altering genetic material.
At the heart of CRISPR-based Gene Editing is the Cas9 protein, a molecular scalpel guided by RNA molecules. The process begins with the design of a guide RNA that matches the target DNA sequence. When introduced into a cell, the guide RNA directs the Cas9 protein to the intended DNA location. Cas9 then makes a precise cut at the target site. This cut triggers the cell's natural DNA repair machinery, which can introduce insertions, deletions, or even precise genetic modifications, leading to altered gene function.
Fig 1. The potential applications of CRISPR-Cas systems in genome editing. (Wan L, et al., 2021)
CRISPR-based Gene Editing emerged from foundational research into the bacterial immune system and has rapidly evolved since its discovery. The technology's potential for correcting genetic mutations implicated in diseases has sparked significant interest in the medical field. Moreover, its applications span agriculture, biofuel production, and bioremediation. Ongoing research focuses on enhancing the precision and efficiency of CRISPR systems, minimizing off-target effects, and developing delivery methods for various cell types.
From consultation to validation, we offer end-to-end solutions.
We serve a broad spectrum of industries, expanding CRISPR's reach.
Precision and Efficiency
Our expertise ensures high specificity and minimal off-target effects.
We leverage the latest CRISPR-Cas systems and delivery methods.
CD Biosynsis specializes in providing exceptional services in the field of synthetic biology. By choosing our service platform, you have access to our expertise, advanced technologies, and personalized support to take your research to new heights. Contact us to know more details about our services.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.